Cargando…

The cost‐effectiveness and budgetary impact of a dolutegravir‐based regimen as first‐line treatment of HIV infection in India

INTRODUCTION: Dolutegravir (DTG)‐based antiretroviral therapy (ART) is recommended for first‐line HIV treatment in the US and Europe. Efavirenz (EFV)‐based regimens remain the standard of care (SOC) in India. We examined the clinical and economic impact of DTG‐based first‐line ART in the setting of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Amy, Kumarasamy, Nagalingeswaran, Huang, Mingshu, Paltiel, A David, Mayer, Kenneth H, Rewari, Bharat B, Walensky, Rochelle P, Freedberg, Kenneth A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878415/ https://www.ncbi.nlm.nih.gov/pubmed/29603882 http://dx.doi.org/10.1002/jia2.25085

Ejemplares similares

2000. Rapid, Point-of-care Diagnosis of Tuberculosis with Novel Truenat Assay: Cost-Effectiveness and Budgetary Impact Analysis for India’s Public Sector
por: Lee, David J, et al.
Publicado: (2018)

Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India
por: Freedberg, Kenneth A., et al.
Publicado: (2018)

Clinical Impact and Cost-Effectiveness of Expanded Voluntary HIV Testing in India
por: Venkatesh, Kartik K., et al.
Publicado: (2013)

The Cost-Effectiveness of Tuberculosis Preventive Therapy for HIV-Infected Individuals in Southern India: A Trial-Based Analysis
por: Pho, Mai T., et al.
Publicado: (2012)

Cost-Effectiveness of HIV Testing Referral Strategies among Tuberculosis Patients in India
por: Uhler, Lauren M., et al.
Publicado: (2010)

Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India’s public sector
por: Lee, David J., et al.
Publicado: (2019)

Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa
por: Paltiel, A. David, et al.
Publicado: (2017)

Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d’Ivoire: A model-based analysis
por: Ouattara, Eric N., et al.
Publicado: (2019)

Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d'Ivoire Appraisal
por: Losina, Elena, et al.
Publicado: (2009)

Mobile HIV Screening in Cape Town, South Africa: Clinical Impact, Cost and Cost-Effectiveness
por: Bassett, Ingrid V., et al.
Publicado: (2014)

The Survival Benefits of Antiretroviral Therapy in South Africa
por: April, Michael D., et al.
Publicado: (2014)

Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection
por: Chaillon, Antoine, et al.
Publicado: (2019)

Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States
por: Paltiel, A. David, et al.
Publicado: (2020)

COVID-19 screening strategies that permit the safe re-opening of college campuses
por: Paltiel, A. David, et al.
Publicado: (2020)

Scaling Up the 2010 World Health Organization HIV Treatment Guidelines in Resource-Limited Settings: A Model-Based Analysis
por: Walensky, Rochelle P., et al.
Publicado: (2010)

Cost-Effectiveness of Genotype Testing for Primary Resistance in Brazil
por: Luz, Paula M., et al.
Publicado: (2015)

Budgetary control in academic libraries
por: Martin, Murray S
Publicado: (1978)

Notes and Proposals on Budgetary Calculations
Publicado: (1962)

Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions
por: Ciaranello, Andrea L, et al.
Publicado: (2011)

Routine HIV Screening in France: Clinical Impact and Cost-Effectiveness
por: Yazdanpanah, Yazdan, et al.
Publicado: (2010)

Budgetary Arrangements for the ISR Programme in the Future
Publicado: (1970)

Budgetary Arrangements for the ISR Programme in the Future
Publicado: (1970)

Budgetary Arrangements for the ISR Programme in the Future
Publicado: (1970)

Examination of the Consequences of Suggested Budgetary Cuts
Publicado: (1957)

Prevalence and factors associated with renal dysfunction in patients on tenofovir disoproxil fumarate-based antiretroviral regimens for HIV infection in Southern India
por: Kumarasamy, Nagalingeswaran, et al.
Publicado: (2018)

Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness
por: Yazdanpanah, Yazdan, et al.
Publicado: (2013)

Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection
por: Walensky, Rochelle P., et al.
Publicado: (2016)

The cost‐effectiveness of HIV pre‐exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil
por: Luz, Paula M, et al.
Publicado: (2018)

Reliability, Validity, and Factor Structure of the Internalized AIDS-Related Stigma Scale in Southern India
por: Chan, Brian T., et al.
Publicado: (2019)

The HIV cure research agenda: the role of mathematical modelling and cost-effectiveness analysis
por: Freedberg, Kenneth A, et al.
Publicado: (2015)

The Clinical and Economic Impact of Point-of-Care CD4 Testing in Mozambique and Other Resource-Limited Settings: A Cost-Effectiveness Analysis
por: Hyle, Emily P., et al.
Publicado: (2014)

Association between internalized stigma and depression among HIV-positive persons entering into care in Southern India
por: Chan, Brian T, et al.
Publicado: (2017)

Budgetary targets as cost-containment measure in the Swiss healthcare system? Lessons from abroad()
por: Braendle, Thomas, et al.
Publicado: (2020)

Sugammadex: Appropriate Use in the Context of Budgetary Constraints
por: Cammu, Guy
Publicado: (2018)

Effectiveness of first-line antiretroviral therapy in the IPEC cohort, Rio de Janeiro, Brazil
por: Cardoso, Sandra W, et al.
Publicado: (2014)

Using national laboratory data to assess cumulative frequency of linkage after transfer to community‐based HIV clinics in South Africa
por: Bassett, Ingrid V, et al.
Publicado: (2019)

Cost-Utility Analysis of Dolutegravir- Versus Efavirenz-Based Regimens as a First-Line Treatment in Adult HIV/AIDS Patients in Ethiopia
por: Belay, Yared Belete, et al.
Publicado: (2021)

Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age
por: Ciaranello, Andrea L., et al.
Publicado: (2015)

The Convergence of Disclosure Concerns and Poverty Contributes to Loss to HIV Care in India: A Qualitative Study
por: Perlo, Jared, et al.
Publicado: (2020)

Decreasing cost of public sector first-line ART services in India from 2007-2008 to 2015-2016
por: Kumar, G. Anil, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dh75b19j3rkocu38btqss8ktd8